Thank you, Mr. Chair.
I'd like to thank the witnesses for their insightful testimony.
Ms. Chalifoux, you said that advance requests should not be restricted to cases of neurocognitive disease because that would exclude all other types of medical problems, such as strokes.
For the former, the assumption is that a person received a diagnosis and is still capable of making a decision, but this decision cannot be reviewed afterwards because the person's capacity to give informed consent will have disappeared. For the latter, a person who has had a stroke or who is suffering from another disease may have made a decision 10 years or even 20 years earlier, and it would be possible to develop a mechanism that would review the circumstances every five years, for example.
What you're really suggesting is introducing different regimes depending on the type of advanced directives.
Is that correct?